Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

    Phillips B, Nylander K, Harnaha J, Machen J, Lakomy R, Styche A, Gillis K, Brown L, Lafreniere D, Gallo M, Knox J, Hogeland K, Trucco M, Giannoukakis N.

    Diabetes. 2008 Jun;57(6):1544-55. Epub 2008 Mar 3.PMID: 18316361 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

    Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

    J Immunol. 2004 Oct 1;173(7):4331-41.PMID: 15383562 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    GAD-IgG-inducing CD4+Foxp3+Treg cells suppressing diabetes are involved in the increasing ratio of CD80+:CD86+ CELLS in NOD mice.

    Wang R, Han G, Wang J, Song L, Chen G, Xu R, Zhang C, Yu M, Qian J, Shen B, Li Y.

    Arch Med Res. 2008 Apr;39(3):299-305.PMID: 18279702 [PubMed - indexed for MEDLINE]Related articles

    5.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

    Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

    Diabetologia. 2009 Jul;52(7):1391-9. Epub 2009 May 7.PMID: 19421731 [PubMed - indexed for MEDLINE]Related articles

    7.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    9.

    Insulin administration confers diabetes-preventive properties to NOD mice derived dendritic cells.

    Xiang M, Zou X, Zhang C, Zhao Z, Xu J.

    Immunopharmacol Immunotoxicol. 2007;29(3-4):451-64.PMID: 18075857 [PubMed - indexed for MEDLINE]Related articles

    10.

    Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.

    Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.

    Diabetes. 2007 Aug;56(8):2116-23. Epub 2007 May 11.PMID: 17496235 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    12.

    Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.

    Dahlén E, Hedlund G, Dawe K.

    J Immunol. 2000 Mar 1;164(5):2444-56.PMID: 10679081 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.

    Besin G, Gaudreau S, Ménard M, Guindi C, Dupuis G, Amrani A.

    Diabetes. 2008 Aug;57(8):2107-17. Epub 2008 May 13.PMID: 18477807 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

    Wang CJ, Chou FC, Chu CH, Wu JC, Lin SH, Chang DM, Sytwu HK.

    Diabetes. 2008 Jul;57(7):1861-9. Epub 2008 Apr 16.PMID: 18420489 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.

    Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA.

    J Clin Invest. 2006 Aug;116(8):2252-61.PMID: 16886063 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.

    McInerney MF, Pek SB, Thomas DW.

    Diabetes. 1991 Jun;40(6):715-25.PMID: 2040388 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.

    Stephens LA, Kay TW.

    Int Immunol. 1995 Dec;7(12):1885-95.PMID: 8746558 [PubMed - indexed for MEDLINE]Related articles

    19.

    Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.

    J Immunol. 1996 Oct 15;157(8):3737-43.PMID: 8871677 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data